Analyst Price Targets — NEUP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 5, 2025 12:43 pm | — | H.C. Wainwright | $7.00 | $4.27 | TheFly | Neuphoria Therapeutics price target lowered to $7 from $21 at H.C. Wainwright |
Latest News for NEUP
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Neuphoria Therapeutics confirms it is in talks with Scancell Holdings plc about a possible combination BURLINGTON, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders, today issued the following…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEUP.
U.S. House Trading
No House trades found for NEUP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.